Menu
Back to Journals » Hepatic Medicine: Evidence and Research » Volume 7
Review
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,357 | Dovepress* | 11,452+ | 1,608 | 13,060 | |
| PubMed Central* | 905 | 341 | 1,246 | ||
| Totals | 12,357 | 1,949 | 14,306 | ||
|
*Since 16 April 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar